These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28130210)

  • 1. Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review.
    Winkelhorst D; Murphy MF; Greinacher A; Shehata N; Bakchoul T; Massey E; Baker J; Lieberman L; Tanael S; Hume H; Arnold DM; Baidya S; Bertrand G; Bussel J; Kjaer M; Kaplan C; Kjeldsen-Kragh J; Oepkes D; Ryan G
    Blood; 2017 Mar; 129(11):1538-1547. PubMed ID: 28130210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events.
    Wienzek-Lischka S; Sawazki A; Ehrhardt H; Sachs UJ; Axt-Fliedner R; Bein G
    Arch Gynecol Obstet; 2020 Aug; 302(2):355-363. PubMed ID: 32495019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized Trial.
    Paridaans NP; Kamphuis MM; Taune Wikman A; Tiblad E; Van den Akker ES; Lopriore E; Challis D; Westgren M; Oepkes D
    Fetal Diagn Ther; 2015; 38(2):147-53. PubMed ID: 25896635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61.
    Regan F; Lees CC; Jones B; Nicolaides KH; Wimalasundera RC; Mijovic A;
    BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia.
    Lakkaraja M; Jin JC; Manotas KC; Vinograd CA; Ferd P; Gabor J; Wissert M; Berkowitz RL; McFarland JG; Bussel JB
    Transfusion; 2016 Oct; 56(10):2449-2454. PubMed ID: 27611703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower-dose intravenous immunoglobulins for the treatment of fetal and neonatal alloimmune thrombocytopenia: a cohort study.
    Kamphuis M; Paridaans N; Winkelhorst D; Wikman A; Tiblad E; Lopriore E; Westgren M; Oepkes D
    Transfusion; 2016 Sep; 56(9):2308-13. PubMed ID: 27383293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal and neonatal alloimmune thrombocytopenia: evidence based antenatal and postnatal management strategies.
    Winkelhorst D; Oepkes D; Lopriore E
    Expert Rev Hematol; 2017 Aug; 10(8):729-737. PubMed ID: 28644735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal interventions for fetomaternal alloimmune thrombocytopenia.
    Rayment R; Brunskill SJ; Soothill PW; Roberts DJ; Bussel JB; Murphy MF
    Cochrane Database Syst Rev; 2011 May; (5):CD004226. PubMed ID: 21563140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies.
    Ernstsen SL; Ahlen MT; Johansen T; Bertelsen EL; Kjeldsen-Kragh J; Tiller H
    Am J Obstet Gynecol; 2022 Sep; 227(3):506.e1-506.e12. PubMed ID: 35500612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach.
    Lieberman L; Greinacher A; Murphy MF; Bussel J; Bakchoul T; Corke S; Kjaer M; Kjeldsen-Kragh J; Bertrand G; Oepkes D; Baker JM; Hume H; Massey E; Kaplan C; Arnold DM; Baidya S; Ryan G; Savoia H; Landry D; Shehata N;
    Br J Haematol; 2019 May; 185(3):549-562. PubMed ID: 30828796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal and neonatal alloimmune thrombocytopenia.
    van den Akker ES; Oepkes D
    Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):3-14. PubMed ID: 17936686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia.
    Matusiak K; Patriquin CJ; Deniz S; Dzaja N; Smith JW; Wang G; Nazy I; Kelton JG; Arnold DM
    Transfusion; 2022 Nov; 62(11):2213-2222. PubMed ID: 36239096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of gradual conversion to a less invasive therapeutic strategy for pregnant women with alloimmune thrombocytopenia in the fetus for prevention of intracranial hemorrhage].
    Radder CM; Kanhai HH; de Beaufort AJ; Klumper FJ; Brand A
    Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2015-8. PubMed ID: 11072521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.
    Lakkaraja M; Berkowitz RL; Vinograd CA; Manotas KC; Jin JC; Ferd P; Gabor J; Wissert M; McFarland JG; Bussel JB
    Am J Obstet Gynecol; 2016 Oct; 215(4):471.e1-9. PubMed ID: 27131591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG.
    te Pas AB; Lopriore E; van den Akker ES; Oepkes D; Kanhai HH; Brand A; Walther FJ
    Eur J Pediatr; 2007 Oct; 166(10):1057-63. PubMed ID: 17177068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the contemporary management of fetal and neonatal alloimmune thrombocytopenia in an Australian tertiary obstetric hospital.
    Cook TJ; Qiu CC; Dickinson JE
    Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):321-6. PubMed ID: 22510050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow up of children after antenatal treatment for alloimmune thrombocytopenia.
    Radder CM; de Haan MJ; Brand A; Stoelhorst GM; Veen S; Kanhai HH
    Early Hum Dev; 2004 Oct; 80(1):65-76. PubMed ID: 15363839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?
    Mechoulan A; Kaplan C; Muller JY; Branger B; Philippe HJ; Oury JF; Ville Y; Winer N;
    J Matern Fetal Neonatal Med; 2011 Apr; 24(4):564-7. PubMed ID: 20822329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy.
    Sun D; Shehata N; Ye XY; Gregorovich S; De France B; Arnold DM; Shah PS; Malinowski AK
    Blood; 2016 Sep; 128(10):1329-35. PubMed ID: 27402971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and Neonatal Outcomes of Pregnancies with Fetal/Neonatal Alloimmune Thrombocytopenia: A Single-Center Retrospective Cohort Study.
    Ronzoni S; Keunen J; Shah PS; Kelly EN; Windrim R; Seaward PG; Ryan G
    Fetal Diagn Ther; 2019; 45(2):85-93. PubMed ID: 29669341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.